LIMN · Liminatus Pharma, Inc.
$5.16
At close · Aug 21
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“management has concluded that there is substantial doubt about its ability to continue as a going concern for one year after the date that the accompanying unaudited condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$6.93M
Shares
1.34M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-18 | — | |
| 10-Q | 2026-08-14 | 2026-06-30 | |
| 8-K | 2026-08-04 | 2026-08-03 | |
| 8-K | 2026-07-30 | 2026-07-29 | |
| 8-K | 2026-07-24 | 2026-07-20 | |
| DEF 14A | 2026-07-13 | 2026-08-03 | |
| 8-K | 2026-07-06 | 2026-06-29 | |
| 8-K | 2026-06-03 | — | |
| 8-K | 2026-05-27 | 2026-05-20 | |
| 8-K | 2026-05-20 | 2026-05-17 | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| 8-K | 2026-03-04 | 2026-02-27 | |
| 8-K | 2026-02-18 | 2026-02-17 | |
| 8-K | 2026-02-09 | 2026-02-06 | |
| 8-K | 2026-01-26 | 2026-01-15 | |
| 8-K | 2025-11-25 | 2025-11-19 | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 10-Q | 2025-10-06 | 2025-06-30 | |
| 8-K | 2025-08-25 | 2025-08-22 | |
| 8-K | 2025-08-14 | — | |
| 8-K | 2025-07-17 | 2025-07-16 | |
| 8-K | 2025-07-11 | 2025-07-10 | |
| 8-K | 2025-07-03 | 2025-07-02 | |
| 8-K | 2025-06-24 | 2025-06-23 | |
| 8-K | 2025-06-24 | — | |
| 8-K | 2025-06-04 | 2025-05-29 | |
| 10-Q | 2025-06-02 | 2025-03-31 | |
| 8-K/A | 2025-06-02 | 2025-04-30 | |
| 8-K | 2025-05-06 | 2025-04-30 |
Showing 1–30 of 30 filings